Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 28Unknown 21Recruiting 14Active not recruiting 6Terminated 5Not yet recruiting 5Withdrawn 3Enrolling by invitation 1

Sponsor Class

OTHER 6

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 2Thoracic 2Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Smoking Cessation 2Neoplasms 2Lung Neoplasms 2Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Neoplasm Metastasis 1Motor Activity 1Lymphoma 1Leukemia 1Inflammation 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

pembrolizumab 439Carboplatin 322Nivolumab 298Cyclophosphamide 286Specimen Handling 271Magnetic Resonance Spectroscopy 259Cisplatin 250Paclitaxel 249Radiotherapy 230Dexamethasone 184Biopsy 182Gemcitabine 180durvalumab 171atezolizumab 152Doxorubicin 141Rituximab 138Lenalidomide 136Ipilimumab 134Docetaxel 132Bevacizumab 132Radiation 121Capecitabine 120Oxaliplatin 116Etoposide 116Radiosurgery 113Fluorouracil 112Pemetrexed 109fludarabine 106venetoclax 102Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Active not recruiting × Hematologic Tests × Clear all
NCT03654105 2026-03-27

SMILE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Active not recruiting
2,000 enrolled
Thoracic

Inflammation, Lung Neoplasms, Motor Activity, Smoking Cessation

NCT05766046 2026-03-27

RISP

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Active not recruiting
7,324 enrolled
Thoracic

Cardiovascular Diseases, Lung Neoplasms, Smoking Cessation, Pulmonary Disease, Chronic Obstructive

NCT03409016 2025-09-05

Biomarkers of Immune-Related Toxicity

University of Colorado, Denver

Active not recruiting
69 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT06979921 2025-08-14

PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale BREAST Cancers, PERCEIVE-BREAST

The First Affiliated Hospital with Nanjing Medical University

Active not recruiting
496 enrolled
Tumor-Agnostic

Neoplasms

NCT04541212 2025-06-15

CarChem

Montreal Heart Institute

Active not recruiting
169 enrolled
BreastLymphoidOther hematologic neoplasm

Breast Neoplasms, Leukemia, Lymphoma

NCT06730035 2024-12-12

PRediction of Outcomes and PERsonalized Radiotherapy by Biomarkers and Functional Imaging

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase NA Active not recruiting
30 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡